Journal of
Public Health and Epidemiology

  • Abbreviation: J. Public Health Epidemiol.
  • Language: English
  • ISSN: 2141-2316
  • DOI: 10.5897/JPHE
  • Start Year: 2009
  • Published Articles: 612

Full Length Research Paper

Interaction of sex with age at diagnosis and radiation therapy in the survival of pediatric acute lymphoblastic leukemia

Jobayer Hossain*
  • Jobayer Hossain*
  • 1Nemours Biomedical Research, A I duPont Hospital for Children, Wilmington, DE 19803, USA. 2The Department of Applied Economics and Statistics, University of Delaware, Newark, DE 19716, USA.
  • Google Scholar
Li Xie
  • Li Xie
  • Nemours Biomedical Research, A I duPont Hospital for Children, Wilmington, DE 19803, USA.
  • Google Scholar


  •  Received: 11 February 2014
  •  Accepted: 22 August 2014
  •  Published: 01 September 2014

References

Bhatia S, Sather HN, Heerema NA, Trigg ME, Gaynon PS, Robison LL (2002). Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 100(6):1957-1964.
Crossref
 
Carroll WL, Bhojwani D, Min DJ, Raetz E, Relling M, Davies S, Downing JR, Willman CL, Reed JC (2003). Pediatric acute lymphoblastic leukemia. American Society of Hematology Education Program 102-131.
Crossref
 
Chessells JM, Richards SM, Bailey CC, Lilleyman JS, Eden OB (1995). Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials. Br. J. Haematol. 89(2):364-372.
Crossref
PubMed
 
Dördelmann M, Reiter A, Borkhardt A, Ludwig W D, Gotz N, Viehmann S, Gadner H, Riehm H, Schrappe M (1999). Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 94:1209-1217.
PubMed
 
Hilden JM, Frestedt JL, Moore RO, Heerema NA, Arthur DC, Reaman GH, Kersey JH (1995). Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4;11)(q21;q23). Blood 86(10):3876-3882.
PubMed
 
Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2013). SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD. Accessed December 24, 2013.
 
Kadan-Lottick NS, Ness KK, Bhatia S, Gurney JG (2003). Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA 290(15):2008-2014.
Crossref
 
Lanning M, Garwicz S, Hertz H, Jonmundsson G, Kreuger A, Lie SO, Moe PJ, Salmi TT, Schröder H, Siimes MA, Wesenbergs F, Yssing M, Ahstrom A, Gustafsson G (1992). Superior treatment results in females with high-risk acute lymphoblastic leukemia in childhood. Acta Paediatr. 81(1):66-68.
Crossref
 
Möricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dördelmann M, Löning L, Beier R, Ludwig WD, Ratei R, Harbott J, Boos J, Mann G, Niggli F, Feldges A, Henze G, Welte K, Beck JD, Klingebiel T, Niemeyer C, Zintl F, Bode U, Urban C, Wehinger H, Niethammer D, Riehm H, Schrappe M; German-Austrian-Swiss ALL-BFM Study Group (2008). Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 111(9):4477-4489.
Crossref
 
Möricke A, Zimmermann M, Reiter A, Gadner H, Odenwald E, Harbott J, Ludwig WD, Riehm H, Schrappe M (2005). Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95. Klin. Padiatr. 217(6):310-320.
Crossref
 
Nachman J, Sather HN, Cherlow JM, Sensel MG, Gaynon PS, Lukens JN, WolffL, Trigg ME (1998). Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: A report from the children's cancer group. J. Clin. Oncol. 16:920-930.
PubMed
 
Pui CH, Behm FG, Downing JR, Hancock ML, Shurtleff SA, Ribeiro RC, Head DR, Mahmoud HH, Sandlund JT, Furman WL (1994). 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J. Clin. Oncol. 12:909-915.
PubMed
 
Pui CH, Behm FG, Crist WM (1993). Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 82(2):343-62.
PubMed
 
Pui CH, Boyett JM, Relling MV, Harrison PL, Rivera GK, Behm FG, Sandlund JT, Ribeiro RC, Rubnitz JE, Gajjar A, Evans WE (1999). Sex differences in prognosis for children with acute lymphoblastic leukemia. J. Clin. Oncol. 17(3):818-824.
PubMed
 
Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV (2009). Treating childhood acute lymphoblastic leukemia without cranial irradiation. N. Engl. J. Med. 360(26):2730-41.
Crossref
 
Pui CH (1997). Acute lymphoblastic leukemia. Pediatr. Clin. North Am. 44:831-846.
Crossref
 
Reaman G, Zeltzer P, Bleyer WA, Amendola B, Level C, Sather H, Hammond D (1985). Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group. J. Clin. Oncol. 3(11):1513-1521.
PubMed
 
Reaman GH, Sposto R, Sensel MG, Lange BJ, Feusner JH, Heerema NA, Leonard M, Holmes EJ, Sather HN, Pendergrass TW, Johnstone HS, O'Brien RT, Steinherz PG, Zeltzer PM, Gaynon PS, Trigg ME, Uckun FM (1999). Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J. Clin. Oncol. 17:445-455.
PubMed
 
Rubnitz JE, Shuster JJ, Land VJ, Link MP, Pullen DJ, Camitta BM, Pui CH, Downing JR, Behm FG (1997). Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group study. Blood 89(4):1143-1146.
PubMed
 
Sather H, Miller D, Nesbit M, Heyn R, Hammond D (1981). Differences in prognosis for boys and girls with acute lymphoblastic leukaemia. Lancet 1(8223):739-43.
Crossref
 
Sather HN (1986). Age at diagnosis in childhood acute lymphoblastic leukemia. Med. Pediatr. Oncol. 14(3):166-172.
Crossref
 
Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, MoghrabiA, Samson Y, Schorin MA, Arkin S, Declerck L, Cohen HJ, Sallan SE (2001). Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood 97 (5):1211-8.
Crossref
 
Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reamon G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R (1996). Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J. Clin. Oncol. 14(1):18-24.
PubMed